Key result
Female sex is linked to benign cardiac masses and males to metastatic tumors, without mortality differences.
Why the study?
Cardiac masses represent a heterogeneous clinical scenario, and sex-related differences among these patients remain to be established.
Are there sex-related disparities in the clinical presentation and outcomes of patients with cardiac masses?
Cohort (n=321)
No
Are there sex-related disparities in the clinical presentation and outcomes of patients with cardiac masses?
Although there are significant sex-related differences in the histotype prevalence of cardiac masses, sex is not an independent predictor of mortality.
Background. Cardiac masses (CM) represent a heterogeneous clinical scenario, and sex-related differences of these patients remain to be established. Purpose: To evaluate sex-related disparities in CMs regarding clinical presentation and outcomes. Material and Methods. The study cohort included 321 consecutive patients with CM enrolled in our Centre between 2004 and 2022. A definitive diagnosis was achieved by histological examination or, in the case of cardiac thrombi, with radiological evidence of thrombus resolution after anticoagulant treatment. All-cause mortality at follow-up was evaluated. Multivariable regression analysis assessed the potential prognostic disparities between men and women. Results. Out of 321 patients with CM, 172 (54%) were female. Women were more frequently younger (p = 0.02) than men. Regarding CM histotypes, females were affected by benign masses more frequently (with cardiac myxoma above all), while metastatic tumours were more common in men (p < 0.001). At presentation, peripheral embolism occurred predominantly in women (p = 0.03). Echocardiographic features such as greater dimension, irregular margin, infiltration, sessile mass and immobility were far more common in men. Despite a better overall survival in women, no sex-related differences were observed in the prognosis of benign or malignant masses. In fact, in multivariate analyses, sex was not independently associated with all-cause death. Conversely, age, smoking habit, malignant tumours and peripheral embolism were independent predictors of mortality. Conclusions. In a large cohort of cardiac masses, a significant sex-related difference in histotype prevalence was found: Benign CMs affected female patients more frequently, while malignant tumours affected predominantly men. Despite better overall survival in women, sex did not influence prognosis in benign and malignant masses.
No takes yet. Share an insight, caveat, or question.
Angeli et al. (2023) conducted a cohort in Cardiac masses (n=321). Female sex vs. Male sex was evaluated on All-cause mortality. Female sex was associated with a higher prevalence of benign cardiac masses, while metastatic tumors were more common in men (p<0.001), but sex was not independently associated with mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: